Hospital
Mission Hospital INC
Mission Hospital INC was paid $6.71M by Medicaid between Jan 2018 and Jan 2019, across 140 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 21% of everything it billed.
33Billing provider infoMISSION HOSPITAL INC
ASHEVILLE, NC 28801
ASHEVILLE, NC 28801
33aNPI1881626075assigned 07/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.71M
24GClaims136,854
24DCodes billed140
24AFirst – last monthJan 2018 – Jan 2019
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#60 of 92
Median peer was paid$11.47M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 125,393 | $6.15M | |
| 2019 | 11,461 | $559K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 21% | 1,532 | 1,367 | $1.38M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 7,405 | 7,059 | $1.29M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 9,573 | 9,212 | $1.18M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.1% | 2,300 | 2,109 | $609K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.7% | 14,744 | 13,932 | $249K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.6% | 644 | 630 | $239K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 3.3% | 848 | 827 | $220K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.6% | 125 | 124 | $110K |
| J3490 | Unclassified drugs | 1.5% | 23,334 | 12,515 | $98K |
| 80053 | Comprehensive metabolic panel | 1.5% | 9,490 | 8,668 | $98K |
| 93320 | 1.4% | 862 | 840 | $94K | |
| 93325 | 1.3% | 894 | 868 | $88K |
128 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 11,824 | $85K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 1,409 | $70K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,606 | $58K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 118 | $54K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 952 | $51K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,476 | $46K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,486 | $43K |
| 81229 | <1% | 40 | $42K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,243 | $35K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,387 | $33K |
| G0378 | Hospital observation service, per hour | <1% | 228 | $30K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 131 | $28K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,150 | $28K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 113 | $26K |
| 95816 | <1% | 204 | $25K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,845 | $17K |
| 86780 | <1% | 1,130 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 386 | $16K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 500 | $15K |
| 86703 | <1% | 1,115 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,358 | $14K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 320 | $14K |
| 72081 | <1% | 177 | $13K | |
| 93922 | <1% | 314 | $13K | |
| 81001 | <1% | 4,155 | $13K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,021 | $13K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 61 | $13K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 204 | $12K |
| 96101 | <1% | 304 | $11K | |
| 95813 | <1% | 58 | $10K | |
| 84439 | <1% | 971 | $10K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 296 | $9K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $9K |
| 72170 | <1% | 124 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 181 | $7K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 251 | $6K |
| 87070 | <1% | 600 | $6K | |
| 77073 | <1% | 171 | $6K | |
| 81025 | <1% | 373 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 157 | $5K |
| 96040 | <1% | 555 | $5K | |
| 74018 | <1% | 129 | $5K | |
| 84484 | <1% | 486 | $5K | |
| 83690 | <1% | 796 | $5K | |
| 64483 | <1% | 17 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 142 | $4K |
| 87081 | <1% | 593 | $4K | |
| 86850 | <1% | 327 | $4K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 242 | $4K |
| 84466 | <1% | 237 | $4K | |
| 86762 | <1% | 226 | $4K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 375 | $3K |
| 73100 | <1% | 82 | $3K | |
| 87486 | <1% | 113 | $3K | |
| 87581 | <1% | 113 | $3K | |
| 87340 | <1% | 319 | $3K | |
| 83516 | <1% | 231 | $3K | |
| 86738 | <1% | 187 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 52 | $3K |
| 82728 | <1% | 188 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 187 | $3K |
| 82784 | <1% | 212 | $2K | |
| 94010 | <1% | 567 | $2K | |
| 36591 | <1% | 67 | $2K | |
| A9270 | Non-covered item or service | <1% | 1,329 | $2K |
| 80050 | General health panel | <1% | 201 | $2K |
| 83540 | <1% | 237 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 27 | $2K |
| 93880 | <1% | 12 | $2K | |
| 29581 | <1% | 70 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 85 | $1K |
| 92587 | <1% | 39 | $1K | |
| 95819 | <1% | 13 | $1K | |
| 87653 | <1% | 46 | $1K | |
| 80061 | Lipid panel | <1% | 92 | $1K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 216 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 123 | $1K |
| 96131 | <1% | 33 | $1K | |
| 86900 | <1% | 328 | $1K | |
| 86901 | <1% | 328 | $1K | |
| 77072 | <1% | 26 | $1K | |
| 80177 | <1% | 70 | $989.50 | |
| 96112 | <1% | 20 | $960.83 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 927 | $959.12 |
| 87116 | <1% | 69 | $867.31 | |
| 82607 | <1% | 66 | $814.37 | |
| 82746 | <1% | 67 | $812.75 | |
| 87102 | <1% | 69 | $674.15 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 73 | $631.20 |
| 82024 | <1% | 13 | $625.69 | |
| 82951 | <1% | 40 | $576.46 | |
| 87205 | <1% | 123 | $559.61 | |
| 84703 | <1% | 53 | $552.63 | |
| 84481 | <1% | 27 | $548.86 | |
| 87015 | <1% | 69 | $535.71 | |
| 96130 | <1% | 34 | $495.84 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 40 | $491.98 |
| 94664 | <1% | 34 | $471.24 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 86 | $438.01 |
| 87206 | <1% | 69 | $430.76 | |
| 86140 | <1% | 76 | $394.61 | |
| 84403 | <1% | 14 | $386.04 | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 55 | $369.08 |
| 85610 | <1% | 108 | $318.50 | |
| 92567 | <1% | 12 | $291.96 | |
| 29075 | <1% | 19 | $236.17 | |
| 80164 | <1% | 14 | $233.80 | |
| 82150 | <1% | 37 | $229.15 | |
| C1769 | Guide wire | <1% | 16 | $181.24 |
| 96111 | <1% | 183 | $153.04 | |
| 80076 | <1% | 13 | $129.87 | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 14 | $112.84 |
| 96136 | <1% | 34 | $112.80 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 27 | $104.82 |
| 11719 | <1% | 30 | $102.50 | |
| 96137 | <1% | 22 | $92.45 | |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 28 | $90.92 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 13 | $77.51 |
| 85027 | <1% | 13 | $74.12 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 12 | $68.97 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 41 | $63.02 |
| 83735 | <1% | 14 | $58.45 | |
| 85651 | <1% | 16 | $57.46 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 32 | $52.52 |
| 96127 | <1% | 48 | $36.18 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 27 | $26.12 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 124 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHILL, LARRY (VP FINANCE MEMBER HOSPITALS)
| Provider | Location | Paid |
|---|---|---|
| MH Mission Hospital Mcdowell, LLLP | Marion, NC | $7.65M |
| Hill Resources INC | Abilene, TX | $7.08M |
| MH Mission Hospital Mcdowell, LLLP | Marion, NC | $7.05M |
| MH Angel Medical Center, LLLP | Franklin, NC | $1.86M |
| MH Mission Hospital Mcdowell, LLLP | Nebo, NC | $547K |
| MH Angel Medical Center, LLLP | Franklin, NC | $76K |
| MH Mission Hospital Mcdowell, LLLP | Marion, NC | $47K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.